有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 3-(4-chlorophenyl)sulfanylpropyl-[(2S)-2-hydroxypropyl]azanium | —— | C12H19ClNOS+ |
|
—— | methyl 2,4-dimethyl-5-[(2S)-2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]propanoyl]-1H-pyrrole-3-carboxylate | —— | C18H23N3O4S |
|
—— | 1-[2,5-dimethyl-1-[[(2S)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C19H21N3O4S |
|
—— | 3-(4-Chlorophenyl)sulfanylpropyl-(2-morpholin-4-ium-4-ylethyl)azanium | —— | C15H25ClN2OS+2 |
|
—— | N-[(2R)-butan-2-yl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C12H15N3O3S |
|
—— | N-benzyl-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-propan-2-ylacetamide | —— | C18H19N3O3S |
|
—— | N-(1-cyanocyclohexyl)-2-[(4-hydroxy-6-propylpyrimidin-2-yl)sulfanyl]acetamide | —— | C16H22N4O2S |
|
—— | (2S)-2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]propanenitrile | —— | C10H13N3OS |
|
—— | (2R)-N-(cyclohexylmethyl)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C16H21N3O3S |
|
—— | N-[(3S)-1,1-dioxothiolan-3-yl]-N-ethyl-2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]acetamide | —— | C15H23N3O4S2 |
|
—— | N-[(2R)-butan-2-yl]-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]acetamide | —— | C17H27N3O4S2 |
|
—— | 1-(2-methylsulfanylpyrimidin-4-yl)-N-[(3S)-thiolan-3-yl]piperidin-4-amine | —— | C14H22N4S2 |
|
—— | N-[2-(4-fluorophenyl)ethyl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C16H14FN3O3S |
|
—— | (2S)-N-(cyclohexylcarbamoyl)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C16H20N4O4S |
|
—— | methyl 5-[(2S)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate | —— | C17H17N3O5S |
|
—— | N-[(2S)-butan-2-yl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C12H15N3O3S |
|
—— | 2-[(4-Bromo-2-fluorophenyl)methylsulfanyl]-5-(furan-2-yl)-1,3,4-oxadiazole | —— | C13H8BrFN2O2S |
|
—— | (2S)-N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[(6-oxo-4-propyl-1H-pyrimidin-2-yl)sulfanyl]propanamide | —— | C18H22FN3O2S |
|
—— | 1-[2,5-dimethyl-1-[[(2R)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanylethanone | —— | C18H22N2O3S |
|
—— | N-[(E)-1-(2,5-dimethylfuran-3-yl)ethylideneamino]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C16H20N4O2S |
|
—— | 3-(4-fluorophenyl)sulfanyl-N-[(Z)-(1-methyl-6,7-dihydro-5H-indazol-4-ylidene)amino]propanamide | —— | C17H19FN4OS |
|
—— | (2R)-N-[(1R)-1-phenylethyl]-2-[(6-phenyl-1,2,4-triazin-3-yl)sulfanyl]butanamide | —— | C21H22N4OS |
|
—— | 2-Amino-6-[(2-fluorophenyl)methylsulfanyl]pyridin-1-ium-3,5-dicarbonitrile | —— | C14H10FN4S+ |
|
—— | (2R)-2-thiophen-2-ylsulfanylbutanedioic acid | —— | C8H8O4S2 |
|
—— | (2R)-2-[(5-benzyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]cyclohexan-1-one | —— | C18H21N3OS |
|
—— | (2S)-2-[(5-benzyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]cyclohexan-1-one | —— | C18H21N3OS |
|
—— | 2-[(Z)-2-hydroxy-4-oxopent-2-enyl]sulfanyl-4-methoxy-6-methylpyridine-3-carbonitrile | —— | C13H14N2O3S |
|
—— | 2-(1-methyltetrazol-5-yl)sulfanyl-N-[(1R)-1-phenylethyl]acetamide | —— | C12H15N5OS |
|
—— | ethyl 2,4-dimethyl-5-[(2S)-2-(1-methyltetrazol-5-yl)sulfanylpropanoyl]-1H-pyrrole-3-carboxylate | —— | C14H19N5O3S |
|
—— | 1-[(3R)-3-(furan-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-2-(1-methyltetrazol-5-yl)sulfanylethanone | —— | C18H18N6O2S |
|
—— | (3S)-3-[[5-(4-methylpiperidin-1-yl)-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]oxolan-2-one | —— | C17H26N4O3S |
|
—— | (3S)-3-[[5-(4-methylpiperidin-1-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]oxolan-2-one | —— | C17H26N4O3S |
|
—— | (3R)-3-[[5-(4-methylpiperidin-1-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]oxolan-2-one | —— | C17H26N4O3S |
|
—— | (3R)-3-[[5-(4-methylpiperidin-1-yl)-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]oxolan-2-one | —— | C17H26N4O3S |
|
—— | 2-(Benzyliminomethyl)-1-benzothiophen-3-one | —— | C16H13NOS |
|
—— | 1-[2,5-dimethyl-1-[[(2R)-oxolan-2-yl]methyl]pyrrol-3-yl]-2-(1-methylimidazol-2-yl)sulfanylethanone | —— | C17H23N3O2S |
|
—— | 2-(1-Methylimidazol-2-yl)sulfanyl-1-(5-phenyl-3,4-dihydropyrazol-2-yl)ethanone | —— | C15H16N4OS |
|
—— | N-[(4-fluorophenyl)methyl]-2-(1-methylimidazol-2-yl)sulfanylacetamide | —— | C13H14FN3OS |
|
—— | (2R)-3-methylbutane-2-thiol | —— | C5H12S |
|
—— | 2-[(5-Benzyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-1-(2,5-dimethyl-1-prop-2-enylpyrrol-3-yl)ethanone | —— | C21H24N4OS |
|
—— | 1-(1-Adamantyl)-2-[(5-benzyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]ethanone | —— | C22H27N3OS |
|
—— | (2S)-2-[(5-benzyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C13H16N4OS |
|
—— | N-[(1R)-1-(1-adamantyl)ethyl]-2-[(5-benzyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C24H32N4OS |
|
—— | 2-[(5-benzyl-4-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-(1-cyanocyclopentyl)acetamide | —— | C18H21N5OS |
|
—— | 2-[1,4-dimethyl-5-[(2-methylphenyl)methyl]-6-oxopyrimidin-2-yl]sulfanyl-N,N-diethylacetamide | —— | C20H27N3O2S |
|
—— | 2-[[4-Methyl-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-5-phenyl-1,3,4-oxadiazole | —— | C17H15N5OS2 |
|
—— | 1-methyl-N-[2-[[4-methyl-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetyl]pyrrole-2-carboxamide | —— | C16H17N5O2S2 |
|
—— | 1-[(4S)-5,5-dimethyl-3-[(Z)-(4-methylsulfanylphenyl)methylideneamino]-2-sulfanylidene-1,3-thiazolidin-4-yl]-1-hydroxy-3-methylurea | —— | C15H20N4O2S3 |
|
—— | 5-[(4-Fluorophenyl)methyl]-3,6-dimethyl-2-prop-2-enylsulfanylpyrimidin-4-one | —— | C16H17FN2OS |
|
—— | (2-Oxo-2-pyrrolidin-1-ylethyl) 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate | —— | C16H20N4O4S |
|